Table 2.
Association of nephrology co-management with quality of care for pooled stage 3 and stage 4 CKD patients
| Unadjusted estimatesa | Adjusted estimatesb | |||||
|---|---|---|---|---|---|---|
| Outcome | Nephrology co-management (n = 341) | Solo PCP management (n = 2777) | p value | Nephrology co-management | Solo PCP management | p value |
| Serum eGFRc | 100 % | 93 % | P < 0.0001 | 98 % | 94 % | P < 0.0001 |
| Urine protein | 87 % | 37 % | P <0.0001 | 82 % | 36 % | P < 0.0001 |
| ACE/ARB prescription | 81 % | 65 % | P < 0.0001 | 77 % | 69 % | P = 0.03 |
| BP <140/90 | 68 % | 72 % | P = 0.15 | 70 % | 73 % | P = 0.41 |
| BP <130/80 | 47 % | 45 % | P = 0.40 | 47 % | 46 % | P = 0.68 |
| Mean | Mean | Weighted estimate | Weighted estimate | |||
| Systolic, mmHg | 133.1 | 132.4 | P = 0.54 | 132.6 | 130.8 | P = 0.15 |
| Diastolic, mmHg | 70.9 | 72.1 | P = 0.13 | 69.0 | 70.2 | P = 0.12 |
aAll estimates account for clustering by PCP
bWeighted percentage and p value estimated by multivariate model accounting for clustering by PCP and adjusting for age, gender, race/ethnicity, eGFR, hypertension, diabetes, and number of PCP visits
cLinear model due to 100 % rate in co-management group